Search inside Autoimmune Disease
24/7 Customer Support
Oncology and autoimmune diseases are still untouched by them due to which significant opportunities are left untapped.
NANOPASS LICENSED ITS MICRONJET NEEDLE TO CIRCASSIA, A UK BASED BIOPHARMACEUTICAL COMPANY FOCUSED ON DEVELOPING AND COMMERCIALISING DRUGS FOR ALLERGY AND AUTOIMMUNE DISEASES.
IT FOCUSES ON THERAPY AREAS SUCH AS RESPIRATORYCARDIOVASCULAR AND METABOLIC DISEASE (CVMD)AND CANCER, BESIDES AUTOIMMUNE, INFECTION AND NEUROLOGICAL DISEASES.